Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group

Blijlevens, Nicole and Schwenkglenks, Matthias and Bacon, Pamela and D'Addio, Alessandra and Einsele, Hermann and Maertens, Johan and Niederwieser, Dietger and Rabitsch, Werner and Roosaar, Ann and Ruutu, Tapani and Schouten, Harry and Stone, Rebecca and Vokurka, Samuel and Quinn, Barry and McCann, Shaun and European Blood, and Marrow Transplantation Mucositis Advisory Group, . (2008) Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group. Journal of clinical oncology, Vol. 26. pp. 1519-1525.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004778

Downloads: Statistics Overview

Abstract

The Prospective Oral Mucositis Audit assessed the incidence, duration, and determinants of severe oral mucositis (OM; WHO oral toxicity scale grades 3 to 4) in patients with multiple myeloma (MM) or non-Hodgkin's lymphoma (NHL) receiving high-dose conditioning chemotherapy before autologous stem-cell transplantation.

Faculties and Departments:	03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:	Schwenkglenks, Matthias
Item Type:	Article, refereed
Article Subtype:	Research Article
Publisher:	American Society of Clinical Oncology
ISSN:	0732-183X
Note:	Publication type according to Uni Basel Research Database: Journal article
Last Modified:	08 Nov 2012 16:23
Deposited On:	08 Nov 2012 16:20

Repository Staff Only: item control page